Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
SGMOQ holding history
Sangamo Therapeutics, Inc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −165,367−100.0% | Sold out | Holders |
| Q4 2024 | 165,367 | $168.7K | <0.1% | +165,367 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −199,788−100.0% | Sold out | Holders |
| Q2 2024 | 199,788 | $71.6K | <0.1% | +199,788 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −4,533−100.0% | Sold out | Holders |
| Q4 2023 | 4,533 | $2.46K | <0.1% | −1,172−20.5% | Reduced | Holders |
| Q3 2023 | 5,705 | $3.42K | <0.1% | −284,009−98.0% | Reduced | Holders |
| Q2 2023 | 289,714 | $376.6K | <0.1% | −551,546−65.6% | Reduced | Holders |
| Q1 2023 | 841,260 | $1.48M | <0.1% | +620,577+281.2% | Added | Holders |
| Q4 2022 | 220,683 | $692.9K | <0.1% | +135,890+160.3% | Added | Holders |
| Q3 2022 | 84,793 | $415.0K | <0.1% | +9,373+12.4% | Added | Holders |
| Q2 2022 | 75,420 | $312.0K | <0.1% | +6,986+10.2% | Added | Holders |
| Q1 2022 | 68,434 | $398.0K | <0.1% | +68,434 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −22,012−100.0% | Sold out | Holders |
| Q3 2021 | 22,012 | $198.0K | <0.1% | +22,012 | New | Holders |